Open AccessA metformin-monoterápia és a szitagliptin/metformin fix kombináció egyéves perzisztenciája
Author(s) -
Gábor Simonyi,
Tamás Ferenci
Publication year - 2016
Publication title -
orvosi hetilap
Language(s) - Hungarian
Resource type - Journals
SCImago Journal Rank - 0.176
H-Index - 21
eISSN - 1788-6120
pISSN - 0030-6002
DOI - 10.1556/650.2016.30423
Subject(s) - metformin , sitagliptin , medicine , discontinuation , fixed dose combination , medical prescription , type 2 diabetes , hazard ratio , diabetes mellitus , pharmacology , endocrinology , confidence interval
In treatment of type 2 diabetes mellitus it is important to reach glycaemic targets. The elements of this are the adequate diet and the patient's adherence to medication.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom